Overview

Evidence-based recommendations on the RD-100i OSNA system and Metasin test for detecting sentinel lymph node metastases in people having breast cancer surgery.

Last reviewed: 19 February 2020

We found nothing new that affects the recommendations in this guidance. For more information, see the review decision.

Diagnostics guidance 8 has been migrated to HealthTech guidance 315. The recommendations and accompanying content remain unchanged.

Next review: This guidance will be reviewed if there is new evidence that is likely to change the recommendations.

Guidance development process

How we develop NICE HealthTech guidance